Sosrane Inhaler

Sosrane Inhaler contains the active component Isoflurane. It is a volatile inhalation anesthetic used in anaesthesia and surgery. It belongs to the class of halogenated ethers, which induce and maintain general anaesthesia. In emergency surgeries such as trauma cases or surgeries for life-threatening conditions, it may be required for rapid induction of anaesthesia. It can be used for certain diagnostic and therapeutic procedures requiring general anaesthesia. While less commonly used during childbirth owing to concerns about uterine relaxation, it may be used in some situations during caesarean sections when other anaesthetics are unsuitable. Before use, a thorough assessment of the patient's health and an individualised anaesthesia plan are typically established to ensure safety and effectiveness during the procedure. Patients with a known allergy or hypersensitivity to Isoflurane or other halogenated ethers should not receive it. The liver metabolises it to a small extent; patients with severe liver dysfunction should not take this medication. Patients with a personal or family history of malignant hyperthermia should also avoid it. Patients with severe respiratory disorders such as advanced chronic obstructive pulmonary disease (COPD) may require careful consideration of its risks and benefits. Patients with unstable cardiovascular conditions such as uncontrolled hypertension or severe arrhythmias may require careful monitoring. It can be used in older adults when appropriate precautions are taken. Isoflurane is suitable for paediatric patients undergoing surgery, as it can be titrated to provide the appropriate level of anaesthesia for children.

Sosrane Inhaler is used in the following: General anesthesia Surgical procedures Emergency surgery Diagnostic and therapeutic procedures Pediatric surgery Veterinary medicine

Sosrane Inhaler induces and maintains general anesthesia by altering the activity of neurotransmitters in the central nervous system. It enhances the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), which reduces the transmission of signals between nerve cells. This leads to a reversible loss of consciousness, amnesia, analgesia (pain relief), and muscle relaxation, ensuring that patients remain immobile and pain-free during surgical procedures.

Sosrane Inhaler is typically administered through inhalation, specifically by using a specialized anesthesia delivery system. It is inhaled as a vapor to induce and maintain general anesthesia during medical and surgical procedures.

Sosrane Inhaler causes side effects like all medications, although not everyone will experience them. Serious Respiratory depression Cardiovascular effects Malignant hyperthermia Allergic reactions Liver and kidney function changes Neurological effects Common Nausea and vomiting Headache Sore throat and cough Shivering Confusion or memory changes

Before taking Sosrane Inhaler, a thorough patient assessment is conducted, including medical history, allergies, and preexisting conditions. Continuous monitoring of vital signs, ventilation, and anesthetic depth is maintained throughout the procedure to promptly detect and address any changes in the patient's condition. Attention is given to proper patient positioning to prevent pressure ulcers and nerve damage. Infection control measures are rigorously observed to minimize the risk of surgical site infections. Adequate fluid management and intravenous support are administered to maintain hydration and circulation.